Spero Therapeutics Inc
F:2HA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Spero Therapeutics Inc
F:2HA
|
US |
|
S
|
State Bank of India
SWB:SID
|
IN |
|
T
|
Trupanion Inc
F:TPW
|
US |
|
C
|
China Minsheng Banking Corp Ltd
XMUN:GHFH
|
CN |
|
eEducation Albert AB
F:9IX
|
SE |
|
P
|
Public Storage
F:PUP
|
US |
Wall St Price Targets
2HA Price Targets Summary
Spero Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 2HA is 2.765 EUR with a low forecast of 2.738 EUR and a high forecast of 2.846 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2HA's stock price target?
Price Target
2.765
EUR
According to Wall Street analysts, the average 1-year price target for 2HA is 2.765 EUR with a low forecast of 2.738 EUR and a high forecast of 2.846 EUR.
What is the Revenue forecast for Spero Therapeutics Inc?
Projected CAGR
-20%
Over the last 9 years, the compound annual growth rate for Revenue has been 80%. The projected CAGR for the next 3 years is -20%.
What is the Net Income forecast for Spero Therapeutics Inc?
Projected CAGR
129%
The compound annual growth rate for Net Income over the next 2 years is 129%.
